Workflow
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates
10x Genomics10x Genomics(US:TXG) ZACKS·2025-11-07 07:56

10x Genomics (TXG) came out with a quarterly loss of 0.22pershareversustheZacksConsensusEstimateofalossof0.22 per share versus the Zacks Consensus Estimate of a loss of 0.27. This compares to a loss of 0.3pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof+18.520.3 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.52%. A quarter ago, it was expected that this life science technology company would post a loss of 0.35 per share when it actually produced earnings of $0.28, delivering a surprise of +180%.Over the last four quarters, t ...